You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

DEXTROSE 60% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dextrose 60% In Plastic Container, and when can generic versions of Dextrose 60% In Plastic Container launch?

Dextrose 60% In Plastic Container is a drug marketed by B Braun, Baxter Hlthcare, and Hospira. and is included in four NDAs.

The generic ingredient in DEXTROSE 60% IN PLASTIC CONTAINER is dextrose. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dextrose profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DEXTROSE 60% IN PLASTIC CONTAINER?
  • What are the global sales for DEXTROSE 60% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for DEXTROSE 60% IN PLASTIC CONTAINER?
Summary for DEXTROSE 60% IN PLASTIC CONTAINER
Drug patent expirations by year for DEXTROSE 60% IN PLASTIC CONTAINER

US Patents and Regulatory Information for DEXTROSE 60% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017995-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hospira DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 019346-001 Jan 25, 1985 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Baxter Hlthcare DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017521-005 Mar 26, 1982 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Baxter Hlthcare DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047-002 Jul 2, 1991 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

DEXTROSE 60% IN PLASTIC CONTAINER Market Analysis and Financial Projection Experimental

Dextrose 60% in Plastic Container: Market Dynamics and Financial Trajectory

Introduction

Dextrose, a simple sugar derived from cornstarch, is widely used in various industries, including pharmaceuticals, food and beverages, and personal care products. When it comes to medical applications, dextrose solutions, such as Dextrose 60% in plastic containers, play a crucial role in patient care. Here, we delve into the market dynamics and financial trajectory of this specific product.

Market Overview

The global dextrose market is experiencing significant growth, driven by increasing demand from various sectors. The market size is projected to reach USD 8.6 billion by 2027, growing at a CAGR of 7.8% from 2022 to 2027[1].

Pharmaceutical Applications

Dextrose solutions, particularly Dextrose 60% in plastic containers, are essential in the pharmaceutical sector for intravenous administration. These solutions are used for fluid replenishment and caloric supply, making them vital in clinical settings[2].

Clinical Use

Dextrose Injection, USP, is a sterile, nonpyrogenic solution that provides water and calories to patients. It is often used in cases requiring rapid fluid and caloric replenishment, and it can induce diuresis depending on the patient's clinical condition[2].

Market Drivers

Several factors are driving the demand for dextrose solutions in the pharmaceutical market:

Health-Conscious Consumers

The increasing health awareness among consumers, particularly the desire to reduce sugar intake, has led to a surge in demand for dextrose-based products. This trend is evident in the food and beverage industry but also translates to pharmaceutical applications where dextrose is preferred over other sugars due to its compatibility and efficacy[1].

Growing Pharmaceutical Sector

The pharmaceutical industry, especially in regions like the Asia-Pacific, is experiencing rapid growth. This growth is fueled by the increasing need for intravenous solutions and other medical applications where dextrose is a key component[1].

Technological Advancements

Advances in production technology have improved the efficiency and quality of dextrose products. This has made dextrose solutions more reliable and consistent, further boosting their demand in the pharmaceutical sector[1].

Regional Market Dynamics

Asia-Pacific Region

The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Factors such as rapid urbanization, population growth, and changing eating habits toward processed foods and beverages in countries like China and India are driving this growth. Additionally, the expanding pharmaceutical and healthcare industries in the region contribute significantly to the demand for dextrose solutions[1].

North America and Europe

In North America and Europe, the demand for dextrose solutions is also on the rise, driven by the importance of corn as a raw material and the growing need for convenience foods and beverages. Government regulations and industrial applications further support the market growth in these regions[1].

Financial Trajectory

Market Size and Growth

The dextrose market, including pharmaceutical applications, is projected to grow significantly. The global dextrose market is expected to reach USD 8.6 billion by 2027, with a CAGR of 7.8% from 2022 to 2027. This growth is indicative of the increasing demand and expanding applications of dextrose solutions[1].

Revenue Streams

The revenue from dextrose solutions in the pharmaceutical sector comes from various sources:

  • Hospital and Clinical Use: Dextrose solutions are widely used in hospitals and clinical settings for patient care, contributing significantly to the revenue.
  • Pharmaceutical Companies: The production and sale of dextrose solutions by pharmaceutical companies also generate substantial revenue.
  • Research and Development: Innovations in dextrose-based products and solutions also contribute to the financial growth of the market[1].

Challenges and Opportunities

Challenges

  • Fluctuating Raw Material Costs: The cost of raw materials, such as corn, can fluctuate, affecting the production costs of dextrose solutions.
  • Alternative Uses of Corn: The use of corn in ethanol production can sometimes divert raw materials away from dextrose production, posing a challenge to supply chain stability[1].

Opportunities

  • Expanding into Emerging Markets: There is a significant opportunity for dextrose solution manufacturers to expand into emerging markets, particularly in the Asia-Pacific region.
  • Advancements in Production Technology: Improving production technologies can enhance efficiency and product quality, making dextrose solutions more competitive and in demand[1].

Key Takeaways

  • The dextrose market, including pharmaceutical applications, is growing rapidly due to increasing demand from health-conscious consumers and the expanding pharmaceutical sector.
  • The Asia-Pacific region is expected to grow at the highest CAGR, driven by urbanization, population growth, and changing eating habits.
  • Technological advancements in production are improving efficiency and product quality.
  • The market faces challenges such as fluctuating raw material costs and alternative uses of corn, but there are significant opportunities for expansion into emerging markets and innovation in production technologies.

FAQs

What is the primary use of Dextrose 60% in plastic containers in the pharmaceutical sector?

Dextrose 60% in plastic containers is primarily used for intravenous administration to provide fluid replenishment and caloric supply to patients.

Which region is expected to grow at the highest CAGR for the dextrose market?

The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period due to rapid urbanization, population growth, and expanding pharmaceutical and healthcare industries.

What are the key drivers of the dextrose market?

Key drivers include increasing demand from health-conscious consumers, growing pharmaceutical and healthcare industries, and technological advancements in production.

What challenges does the dextrose market face?

The market faces challenges such as fluctuating raw material costs and alternative uses of corn, which can affect supply chain stability.

What opportunities exist for the dextrose market?

Opportunities include expanding into emerging markets, particularly in the Asia-Pacific region, and advancements in production technologies to enhance efficiency and product quality.

Sources

  1. MarketsandMarkets: Dextrose Market Industry Analysis | Types, Advantages, and Forecast
  2. Baxter PI: Dextrose Injection, USP in VIAFLO Plastic Container
  3. Goldman Sachs: Weighing the GLP-1 market
  4. MarketsandMarkets: Glucose, Dextrose, and Maltodextrin Market
  5. USDA Rural Development: An Economic Impact Analysis of the U.S. Biobased Products Industry

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.